IP Library Granted Patent US 7,793,871
Granted Patent B2
US 7,793,871 · App. 12/146,297 · Granted Sep 14, 2010

Drug activation process and vibrational mill therefor

Assignee: Eurand Pharmaceuticals Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,793,871
App. No.
12/146,297
Granted
Sep 14, 2010
Kind
B2
Abstract

The invention comprises a process for activating drugs by means of high-energy co-grinding of the drug with a pharmaceutical carrier, characterized by the use of a vibrational mill equipped with means that regulate the vibration frequency. The process, performed by modifying the frequency of vibration and keeping its amplitude constant, produces drug/carrier composites with a constant particle size in which the degree of drug activation increases in proportion to the frequency applied. The invention also includes a vibrational mill suitably modified to perform the process described.

Claims (12)

1. A method for activating a drug in pharmaceutical composites having particles of constant size, comprising subjecting a drug and a pharmaceutical carrier to co-grinding in a vibrational mill equipped with means to regulate vibration frequency while vibration amplitude is kept constant, wherein drug activation degree increases in proportion to the vibration frequency applied while particle size remains constant.

2. The method of claim 1 wherein said vibrational mill includes a motor and said vibration frequency is varied by varying a rotational speed of said motor.

3. The method of claim 2 wherein said rotational speed is between 200 and 4500 rpm.

4. The method of claim 2 wherein said rotational speed is between 500 and 4000 rpm.

5. The method of claim 2 wherein said rotational speed is between 700 and 3500 rpm.

6. The method of claim 1 further comprising providing a potentiometer connected to said vibrational mill, said potentiometer being adapted to determine said vibration frequency of said vibrational mill.

7. The method of claim 6 wherein said potentiometer is adapted to communicate said vibration frequency to an operator.

8. The method of claim 1 , wherein the vibration frequency is between 200 and 4500 rpm.

9. The method of claim 1 , wherein the vibration frequency is between 500 and 4000 rpm.

10. The method of claim 1 , wherein the vibration frequency is between 700 and 3500 rpm.

11. The method of claim 1 , wherein the said means designed to regulate the vibration frequency is a potentiometer connected to the motor of the mill, which can be suitably regulated by an operator.

12. The method of 1 , wherein the drug and carrier are used, optionally pre-mixed, in proportions of between 12:1 and 0.5:1 by weight.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 21, 2016
From: APTALIS PHARMA LIMITED
To: ADARE PHARMACEUTICALS S.R.L.
Reel/Frame 038049/0136 →
CHANGE OF NAME Recorded Oct 7, 2011
From: EURAND PHARMACEUTICALS LIMITED
To: APTALIS PHARMA LIMITED
Reel/Frame 027033/0185 →
Priority Claims (1)
IE 2001/0620 · Jun 29, 2001 · national
Continuity (2)
Division 1048137700
Related Publication 20080251615A1 · Oct 16, 2008